Team Science Awards
The MRA Team Science Awards support multidisciplinary teams advancing high-impact melanoma research with a strong focus on rapid clinical translation.
Funder: Melanoma Research Alliance
Due Dates (Anticipated): September 2026: Letter of Intent (Team Science Awards) | January 2027: Invited Full Proposal (Team Science Awards) | October 2026: Letter of Intent (RTFCCR–MRA Team Science Award) | February 2027: Invited Full Proposal (RTFCCR–MRA Team Science Award)
Funding Amounts: Typical Team Science Award: up to $1,000,000 total over 2-3 years (recent cycles); at least $11.5M in new MRA funding across all mechanisms per cycle.
Summary: Supports collaborative, multidisciplinary teams conducting high-impact melanoma research with rapid clinical translation potential.
Key Information: This is a forecasted opportunity; all deadlines are projected and may shift—check program page for updates.
Description
The Melanoma Research Alliance (MRA) Team Science Awards are the flagship funding mechanism designed to accelerate progress in melanoma prevention, diagnosis, staging, and treatment through collaborative, multidisciplinary research. These awards support teams of Principal Investigators (PIs) with complementary expertise—potentially spanning multiple institutions and countries—to drive transformational advances with strong potential for rapid clinical translation. Special opportunities may be available for projects focused on specific melanoma subtypes or international collaborations.
